The University of Southampton
University of Southampton Institutional Repository

The metabolism of cyclamate to cyclohexylamine in humans during long-term administration

Renwick, A.G., Thompson, J.P., O'Shaughnessy, M. and Walter, E.J. (2004) The metabolism of cyclamate to cyclohexylamine in humans during long-term administration Toxicology and Applied Pharmacology, 196, (3), pp. 367-380. (doi:10.1016/j.taap.2004.01.013).

Record type: Article


A group of 14 subjects, who had been identified from 261 volunteers in a 1-week screen as being able to metabolize the sweetener cyclamate to cyclohexylamine (>0.2% of a daily dose), and 31 nonconverters (<0.2% metabolism) were given calcium cyclamate tablets (equivalent to 250 mg cyclamic acid, 3 times daily) for a period of 13 weeks. The metabolism of cyclamate to cyclohexylamine was determined using twice-weekly timed (3 h) urine collections during week 1–3 and 7–13. Urine specimens were collected on all other study days to investigate day-to-day fluctuations in cyclohexylamine excretion. Analyses of the twice weekly timed urine collections showed that subjects recruited as nonconverters essentially remained nonconverters. Of the converters, three showed consistently low metabolism, five showed erratic metabolism, five showed low metabolism initially, which increased during the latter part of the study, and one subject showed consistently high metabolism throughout the study. Analysis of the day-to-day urine specimens showed marked intrasubject variability. The plasma concentrations of cyclohexylamine measured on weeks 1–3 and 7–13 reflected the urine profiles. The highest individual long-term average steady-state excretion values based on the 3-h urine collections and daily samples were 21%, 23%, 25%, 29%, 34%, and 38%. The maximum % metabolism detected in the high converters occasionally reached the value of 60% reported in previous short-term studies, but this high activity was not maintained, and was followed by periods of lower metabolism. The results of this metabolism study support an acceptable daily intake (ADI) of 0–11 mg/kg body weight per day.

Full text not available from this repository.

More information

Published date: 2004
Keywords: cyclamate metabolism, cyclohexylamine formation, human variability, gut microflora, acceptable daily intake


Local EPrints ID: 27358
PURE UUID: 5e8b29b5-51b3-42d9-98ad-2411b9e94b95

Catalogue record

Date deposited: 25 Apr 2006
Last modified: 17 Jul 2017 16:04

Export record



Author: A.G. Renwick
Author: J.P. Thompson
Author: M. O'Shaughnessy
Author: E.J. Walter

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton:

ePrints Soton supports OAI 2.0 with a base URL of

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.